Does Vitamin D Supplementation Cut Cardiac Risk?
Researchers conducted a study to determine if higher doses of vitamin D supplementation could reduce markers of cardiac injury and strain in older adults with low vitamin D levels.
Category: Treatment Options
Must-Read Insights
Staff's Top Picks
Medicare to Cover Wegovy for Patients at High Cardiovascular Risk
The Centers for Medicare and Medicaid Services announced that it would allow health plans under Medicare Part D to cover Wegovy and other weight-loss medications if they receive FDA approval for an additional medically accepted indication.
Supplement Reduces Blood Sugar Spikes from Blood Pressure Drug
A dietary supplement developed by a UT Southwestern Medical Center researcher significantly reduced high blood sugar caused by a diuretic used to lower blood pressure.
Read More
Choice of Transfusion Method Shows Little Effect for Heart Attack Patients With Anemia
A study found that the type of transfusion approach used to support adults who developed anemia after a heart attack did not make a significant difference in their likelihood of having another heart attack or dying within 30 days.
Read More
FDA Approves Medtronic’s Renal Denervation System for Hypertension
The FDA has approved Medtronic’s Symplicity Spyral renal denervation system for the treatment of hypertension.
Read More
Radial Access Demonstrates Safety and Efficacy in Peripheral Artery Interventions
A recent study indicates that radial access offers a safer and potentially more effective approach than traditional femoral access.
Read More
FDA Approves Medtronic’s Extravascular Defibrillator to Treat Fast Heart Rhythms
The US Food and Drug Administration approved Medtronic’s Aurora EV-ICD MRI SureScan and Epsila EV MRI SureScan defibrillation lead to treat dangerously fast heart rhythms that can lead to sudden cardiac arrest.
Read More
Abelacimab Outperforms Standard Anticoagulant with Marked Bleeding Reduction
Abelacimab, a dual-acting factor XI/XIa inhibitor, demonstrated a significant reduction in bleeding in a head-to-head study comparing a factor XI inhibitor to a direct oral anticoagulant.
Read More
Heart Transplants Safer Than Thought for Adults with Single-Ventricle CHD
Adults with single-ventricle congenital heart disease have higher short-term mortality after heart transplants, but their 10-year survival is comparable to biventricular congenital heart disease patients, revising prior conceptions about transplantation risks for these groups, according to new research.
Read More
Sleep Apnea Patients’ Heart Health Improves with Continuous CPAP Use
Research from the European Respiratory Society International Congress indicates that using a CPAP machine at night can lower cardiovascular disease mortality in OSA patients and may be more effective than weight loss drugs in reducing arterial plaque build-up.
Read More
ECLS Doesn’t Improve Survival in Heart Attack Patients with Cardiogenic Shock
Extracorporeal life support did not reduce 30-day mortality in patients with acute myocardial infarction complicated by cardiogenic shock with planned early revascularization in a new study.
Read More